Scandinavian ChemoTech AB (publ)

OM:CMOTEC B 주식 보고서

시가총액: SEK 39.7m

Scandinavian ChemoTech 미래 성장

Future 기준 확인 2/6

Scandinavian ChemoTech is forecast to grow earnings and revenue by 32.2% and 58.2% per annum respectively.

주요 정보

32.2%

수익 성장률

n/a

EPS 성장률

Medical Equipment 수익 성장32.8%
매출 성장률58.2%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트13 Aug 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

OM:CMOTEC B - 애널리스트의 미래 추정치 및 과거 재무 데이터 (SEK Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202622-7N/AN/A1
12/31/202513-11N/AN/A1
12/31/20247-14N/AN/A1
6/30/20245-17-14-13N/A
3/31/20244-19-19-18N/A
12/31/20233-21-19-18N/A
9/30/20233-22-20-20N/A
6/30/20232-23-21-21N/A
3/31/20230-23-20-19N/A
12/31/20220-23-20-19N/A
9/30/20220-22-23-20N/A
6/30/20220-22-25-22N/A
3/31/20222-20-22-18N/A
12/31/20213-18-22-19N/A
9/30/20213-15-15-13N/A
6/30/20213-12-11-9N/A
3/31/20212-11-12-10N/A
12/31/20201-12-10-8N/A
9/30/20202-14-16-12N/A
6/30/20202-14-16-12N/A
3/31/20204-13-16-12N/A
12/31/20195-12-16-11N/A
9/30/20195-10-10-6N/A
6/30/20196-9-13-8N/A
3/31/20195-9-10-6N/A
12/31/20185-8-9-5N/A
9/30/20184-6-12-9N/A
6/30/20184-6-8-5N/A
3/31/20183-7N/A-9N/A
12/31/20172-8N/A-10N/A
9/30/20172-10N/AN/AN/A
6/30/20172-8N/A-8N/A
3/31/20172-6N/AN/AN/A
12/31/20162-4N/AN/AN/A
9/30/20161-2N/AN/AN/A
6/30/20161-1N/A4N/A
6/30/2015N/A0N/AN/AN/A

애널리스트 미래 성장 예측

수입 대 저축률: CMOTEC B is forecast to remain unprofitable over the next 3 years.

수익 vs 시장: CMOTEC B is forecast to remain unprofitable over the next 3 years.

고성장 수익: CMOTEC B is forecast to remain unprofitable over the next 3 years.

수익 대 시장: CMOTEC B's revenue (58.2% per year) is forecast to grow faster than the Swedish market (0.01% per year).

고성장 수익: CMOTEC B's revenue (58.2% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if CMOTEC B's Return on Equity is forecast to be high in 3 years time


성장 기업 발견